178 related articles for article (PubMed ID: 16567313)
1. [Medical treatment of metastatic or recurrent cancer of the cervix].
de la Motte Rouge T; Pautier P; Hamy AS; Duvillard P; Bruna A; Castaigne D; Morice P; Haie-Meder C; Lhommé C
Bull Cancer; 2006 Mar; 93(3):263-70. PubMed ID: 16567313
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for recurrent cervical cancer.
Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for recurrent and metastatic cervical cancer.
Tao X; Hu W; Ramirez PT; Kavanagh JJ
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
[TBL] [Abstract][Full Text] [Related]
4. Unexpected long-term survival without evidence of disease after salvage chemotherapy for recurrent metastatic cervical cancer: a case series.
Khoury-Collado F; Bowes RJ; Jhamb N; Aghajanian C; Abu-Rustum NR
Gynecol Oncol; 2007 Jun; 105(3):823-5. PubMed ID: 17363045
[TBL] [Abstract][Full Text] [Related]
5. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy in advanced and recurrent cervical cancer. A review.
Park RC; Thigpen JT
Cancer; 1993 Feb; 71(4 Suppl):1446-50. PubMed ID: 8431878
[TBL] [Abstract][Full Text] [Related]
7. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
[TBL] [Abstract][Full Text] [Related]
8. Management of metastatic cervical cancer: review of the literature.
Long HJ
J Clin Oncol; 2007 Jul; 25(20):2966-74. PubMed ID: 17617528
[TBL] [Abstract][Full Text] [Related]
9. Salvage chemotherapy in recurrent or refractory squamous cell cancer of the uterine cervix.
Alberts DS; Garcia DJ
Semin Oncol; 1994 Aug; 21(4 Suppl 7):37-46. PubMed ID: 8091240
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for recurrent cervical cancer.
Cadron I; Van Gorp T; Amant F; Leunen K; Neven P; Vergote I
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S113-8. PubMed ID: 17804044
[TBL] [Abstract][Full Text] [Related]
11. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.
Tambaro R; Scambia G; Di Maio M; Pisano C; Barletta E; Iaffaioli VR; Pignata S
Crit Rev Oncol Hematol; 2004 Oct; 52(1):33-44. PubMed ID: 15363465
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix.
Omura GA
J Natl Cancer Inst Monogr; 1996; (21):123-6. PubMed ID: 9023841
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Colevas AD
J Clin Oncol; 2006 Jun; 24(17):2644-52. PubMed ID: 16763278
[TBL] [Abstract][Full Text] [Related]
14. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
Moore KN; Herzog TJ; Lewin S; Giuntoli RL; Armstrong DK; Rocconi RP; Spannuth WA; Gold MA
Gynecol Oncol; 2007 May; 105(2):299-303. PubMed ID: 17303230
[TBL] [Abstract][Full Text] [Related]
15. [Radiotherapy concomitant with cisplatin chemotherapy in the treatment of cancer of the cervix uteri].
Bild E; Buiuc A; Albulescu E
Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):99-102. PubMed ID: 9524663
[TBL] [Abstract][Full Text] [Related]
16. Optimal therapy for relapsed carcinoma of the cervix after primary chemoradiation.
Mano M; Kerr J
J Clin Oncol; 2004 Dec; 22(24):5021-2; author reply 5022. PubMed ID: 15611523
[No Abstract] [Full Text] [Related]
17. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
[TBL] [Abstract][Full Text] [Related]
18. Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma.
Hsiao SM; Chen CA; Hsu C; Lin HH; Hsieh CY; Wei LH
Anticancer Res; 2008; 28(3B):1887-91. PubMed ID: 18630476
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy in the management of cervical carcinoma.
duPont NC; Monk BJ
Clin Adv Hematol Oncol; 2006 Apr; 4(4):279-86. PubMed ID: 16728939
[TBL] [Abstract][Full Text] [Related]
20. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
